177 related articles for article (PubMed ID: 6095553)
1. Caerulomycin, an antifungal antibiotic with marked in vitro and in vivo activity against Entamoeba histolytica.
Chatterjee DK; Raether W; Iyer N; Ganguli BN
Z Parasitenkd; 1984; 70(5):569-73. PubMed ID: 6095553
[TBL] [Abstract][Full Text] [Related]
2. A patient with intestinal amoebiasis and cutaneous amoebic ulcer.
Morsy TA; Mangoud AM; Saleh WA
J Egypt Soc Parasitol; 2002 Aug; 32(2):425-8. PubMed ID: 12214920
[TBL] [Abstract][Full Text] [Related]
3. Entamoeba histolytica: virulence potential and sensitivity to metronidazole and emetine of four isolates possessing nonpathogenic zymodemes.
Burchard GD; Mirelman D
Exp Parasitol; 1988 Aug; 66(2):231-42. PubMed ID: 2899517
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody-based immunohistochemical demonstration of Entamoeba histolytica in liver tissues of experimentally infected hamster (Mesocricetus auratus).
Sherchand JB; Thammapalerd N; Riganti M; Tharavanij S; Punpoowong B
Int J Parasitol; 1994 Sep; 24(6):909-16. PubMed ID: 7982753
[TBL] [Abstract][Full Text] [Related]
5. The effect of bisamidines of 2,6-diaminoanthraquinone on Entamoeba histolytica infections in rats and hamsters.
Burden EJ; Carvajal SG; Fabio PF; Fields TL; Lin YI; Murdock KC; Lang SA
Experientia; 1979 Jan; 35(1):33-5. PubMed ID: 217714
[TBL] [Abstract][Full Text] [Related]
6. Antiamoebic activity of 3,3'-fluro-4,4'-di-(pyrrolidine-2-ylidene amino)-diphenyl (liroldine), against experimentally infected intestinal and hepatic amoebiasis.
Chatterjee DK; Iyer SN; Venugopalan B; Raether W
Indian J Exp Biol; 1997 Jul; 35(7):765-770. PubMed ID: 9418378
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Entamoeba histolytica cyst passers with metronidazole.
Chongsuphajaisiddhi T; Pairojboot N; Chuenchusin S; Harinasuta T
Southeast Asian J Trop Med Public Health; 1971 Mar; 2(1):29-33. PubMed ID: 4329577
[No Abstract] [Full Text] [Related]
8. Double-blind test of metronidazole and tinidazole in the treatment of asymptomatic Entamoeba histolytica and Entamoeba hartmanni carriers.
Spillmann R; Ayala SC; Sanchez CE
Am J Trop Med Hyg; 1976 Jul; 25(4):549-51. PubMed ID: 183554
[TBL] [Abstract][Full Text] [Related]
9. [Recommendations for treatment of amebiasis. German Society of Pediatric Infectiology e.V. (DGPI), "Parasitology" Working Group].
Hohenschild S
Klin Padiatr; 1998; 210(3):144-5. PubMed ID: 9629551
[No Abstract] [Full Text] [Related]
10. Ketoconazole and other potent antimycotic azoles exhibit pronounced activity against Trypanosoma cruzi, Plasmodium berghei and Entamoeba histolytica in vivo.
Raether W; Seidenath H
Z Parasitenkd; 1984; 70(1):135-8. PubMed ID: 6320547
[No Abstract] [Full Text] [Related]
11. Experimental amoebiasis and the development of anti-amoebic compounds.
Neal RA
Parasitology; 1983 Feb; 86 (Pt 1)():175-91. PubMed ID: 6300739
[No Abstract] [Full Text] [Related]
12. An experimental model for amoebic abscess production in the cheek pouch of the Syrian golden hamster, Mesocricetus auratus.
Beg MA; Kobayashi S; Hussainy AS; Hamada A; Okuzawa E; Smego RA; Hussain R
Parasitol Int; 2004 Sep; 53(3):247-54. PubMed ID: 15468532
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic effect of amide derivatives of trifluoromethionine against the enteric protozoan parasite Entamoeba histolytica.
Sato D; Kobayashi S; Yasui H; Shibata N; Toru T; Yamamoto M; Tokoro G; Ali V; Soga T; Takeuchi T; Suematsu M; Nozaki T
Int J Antimicrob Agents; 2010 Jan; 35(1):56-61. PubMed ID: 19910163
[TBL] [Abstract][Full Text] [Related]
14. Bioactivity of Farnesyltransferase Inhibitors Against
Probst A; Nguyen TN; El-Sakkary N; Skinner D; Suzuki BM; Buckner FS; Gelb MH; Caffrey CR; Debnath A
Front Cell Infect Microbiol; 2019; 9():180. PubMed ID: 31192168
[TBL] [Abstract][Full Text] [Related]
15. Activity of quinfamide against natural infections of Entamoeba criceti in hamsters: a new potent agent for intestinal amoebiasis.
Slighter RG; Yarinsky A; Drobeck HP; Bailey DM
Parasitology; 1980 Aug; 81(1):157-68. PubMed ID: 6252530
[TBL] [Abstract][Full Text] [Related]
16. Intestinal invasive amebiasis: an experimental model in rodents using axenic or monoxenic strains of Entamoeba histolytica.
Anaya-Velázquez F; Martínez-Palomo A; Tsutsumi V; González-Robles A
Am J Trop Med Hyg; 1985 Jul; 34(4):723-30. PubMed ID: 2862801
[TBL] [Abstract][Full Text] [Related]
17. Intestinal amebiasis: a diagnosis not to be missed.
Marcus VA; Ward BJ; Jutras P
Pathol Res Pract; 2001; 197(4):271-4; discussion 275-8. PubMed ID: 11358014
[TBL] [Abstract][Full Text] [Related]
18. 1,4-Bis-[1-methyl-5-nitroimidazolyl-(2-methyleneimino)]-piperazine, a new drug with marked activity against Entamoeba histolytica. Short communication.
Raether W; Seidenath H; Winkelmann E
Arzneimittelforschung; 1977; 27(5):968-9. PubMed ID: 195590
[TBL] [Abstract][Full Text] [Related]
19. Metronidazole hydrazone conjugates: Design, synthesis, antiamoebic and molecular docking studies.
Ansari MF; Siddiqui SM; Agarwal SM; Vikramdeo KS; Mondal N; Azam A
Bioorg Med Chem Lett; 2015 Sep; 25(17):3545-9. PubMed ID: 26174554
[TBL] [Abstract][Full Text] [Related]
20. Experimental muscular amebiasis in hamsters as a biological model.
Chiari L; Guerrero J; Negrão dos Santos C
Z Parasitenkd; 1978 Jul; 56(2):107-14. PubMed ID: 211747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
